Find Clinical Trials | Cedars-Sinai

9 results found

Other

BIVV020 for Prevention and Treatment of Antibody-Mediated Rejection in Adult Kidney Transplant Recipients

The purpose of the study is to evaluate whether an experimental medicine called BIVV020 can prevent antibody-mediated rejection (AMR) in patients with kidney transplants. BIVV020 is a type of antibody that binds to complement proteins. ...

Other

Recurrence Post-Transplant Observational Study in FSGS and MCD

This study focuses on adults and children who have been diagnosed with focal segmental glomerulosclerosis (FSGS) or minimal change disease (MCD) and who have had or are scheduled to have a kidney transplant. The purpose ...

Other

Advancing Transplantation Outcomes in Children

This study focuses on pediatric patients who are receiving a kidney transplant at Cedars-Sinai. The purpose of the study is to determine whether an experimental combination of immunosuppressive drugs, belatacept and sirolimus, preserves kidney ...

Other

ARGX-117 in Improving Allograft Function in Recipients of a Deceased Donor Renal Allograft

This study focuses on people who have been matched to receive a kidney transplant. The study aims to determine whether an experimental drug called ARGX-117 will reduce the patient’s chances of needing dialysis after transplant ...

Other

ARGENX

Primary objective is to evaluate the safety and tolerability of efgartigimod PH20 SC in kidney transplant recipients diagnosed with AMR.